Word: merck
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...most inquisitive, observant, persistent citizens--share a handicap: they can't read yet. They also can't play with matches, focus microscopes or see over lab tables. "Children love to explore the natural world. They love to make sense out of it," says Carlo Parravano, director of the Merck Institute for Science Education, which trains teachers in New Jersey and Pennsylvania. "By fourth grade, we squash that curiosity with the way we teach science...
Indeed, P. Roy Vagelos, a former CEO and chairman of Merck, traveled last fall to China, where he met a number of U.S.-educated Chinese scientists who had returned to work in their homeland. "The new labs are spectacular," he says. "Unbelievable. The equipment leaves nothing to be desired." The government is doling out generous research grants to academic scientists. In all, it invested nearly 110 billion yuan on science in 2004, up from less than 50 billion yuan in 1999. Chinese scientists also get cash awards that can run into thousands of dollars for getting papers published in scholarly...
...been a painful 15 months both for people with arthritis and for the companies that make their painkilling drugs. The once high-flying anti-inflammatories known as cox-2 inhibitors nearly crashed and burned in September 2004, when Merck's popular Vioxx was pulled from the market after a study revealed it could raise the risk of heart attack and stroke. A competitor made by Pfizer, Bextra, was yanked some months later, leaving only Pfizer's Celebrex behind-and a new, required safety warning hasn't exactly done wonders for that drug's appeal. Celebrex sales are off more than...
...VACCINES If all goes well, the FDA could approve the first vaccine for cervical cancer by 2006. A large-scale study presented at a meeting of the Infectious Diseases Society of America in October found that Merck's experimental vaccine Gardasil was 100% effective against two strains of human papillomavirus that cause 70% of all cervical cancers. Another experimental Merck vaccine was tested this year for protection against shingles, the painful blistering disorder caused by the chicken-pox virus. In a trial of more than 38,500 adults 60 and older, the vaccine cut the risk of shingles by more...
...Increase in the share price of Merck the day a jury found its Vioxx drug had not caused a postal worker's heart attack, in the second Vioxx case to reach trial; Merck lost the first in August...